Discount up to 35% for first purchase only this month.

Everclear Peptides logo

Everclear peptides.

Semaglutide
Semaglutide - Image 2

Semaglutide

$75.00

Semaglutide is a long-acting GLP-1 (glucagon-like peptide-1) receptor agonist developed by Novo Nordisk, representing the current standard for single-mechanism metabolic peptide research.

Show COA

Description

Semaglutide is a long-acting GLP-1 (glucagon-like peptide-1) receptor agonist developed by Novo Nordisk, representing the current standard for single-mechanism metabolic peptide research. It mimics endogenous GLP-1 with 94% homology but with extended half-life (~165 hours) due to albumin binding via a C-18 fatty di-acid side chain. With extensive Phase 3 data across diabetes (SUSTAIN trials) and obesity (STEP trials), Semaglutide serves as a benchmark comparator for researchers studying newer metabolic peptides including Tirzepatide and Retatrutide.

Additional information

Weight0.02 lbs
Dimensions3.81 × 1.27 × 1.27 cm
MG

5, 10

Reviews

There are no reviews yet.

Be the first to review “Semaglutide”

Your email address will not be published. Required fields are marked *

I confirm I am 21+ years of age or older.

Purchasers must be 21 years of age or older.

The products shown on this website are intended strictly for laboratory research purposes only and are not for human or animal consumption in any form.